Agility
adds value

ーTEIJIN REGENET Co., Ltd.

Creating a Future
for Regenerative Medicine

ーJapan Tissue
Engineering Co., Ltd.

TEIJIN CDMO, jointly operated by TEIJIN REGENET and J-TEC, offers CDMO service for cell & gene therapy as well as regenerative medicine.

TEIJIN REGENET Co., Ltd.
Japan Tissue Engineering Co., Ltd.

Latest News

TEIJIN CDMO's strength

One-stop solution for manufacturing of cell based products

Accomplishments of 5 regulatory approvals in regenerative medicine

*As of November 2025

Supports of vector manufacturing and overseas clinical trials

Learn more

CDMO services

Facilities

News

Questionnaire
about your needs

Please share your needs for process development, manufacturing,
analysis in cell & gene therapies/regenerative medicines.
(About 5 min)

Answer the questionnaire

Blog and Topics

◆ Exhibition / Seminar Information ◆

Jan. 21. 2026

Topics

◆ Exhibition / Seminar Information ◆
How to unlock Japan’s RM sector opportunity: the role of Japanese CDMOs
Pickup

Dec. 01. 2025

Blog

<Blog 3>How to unlock Japan’s RM sector opportunity: the role of Japanese CDMOs
Key considerations for unlocking Japan’s full cell & gene therapy and regenerative medicine potential

Nov. 28. 2025

Blog

<Blog 2>Key considerations for unlocking Japan’s full cell & gene therapy and regenerative medicine potential
Japan: A Unique Opportunity for Regenerative Medicine and Cell & Gene Therapy

Nov. 10. 2025

Blog

<Blog 1>Japan: A Unique Opportunity for Regenerative Medicine and Cell & Gene Therapy

View all